Sanofi $SNY Shares Bought by Virtu Financial LLC

Virtu Financial LLC lifted its stake in shares of Sanofi (NASDAQ:SNY) by 212.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 31,550 shares of the company’s stock after acquiring an additional 21,466 shares during the quarter. Virtu Financial LLC’s holdings in Sanofi were worth $1,529,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Flagship Harbor Advisors LLC acquired a new stake in shares of Sanofi during the fourth quarter worth $25,000. Measured Wealth Private Client Group LLC acquired a new position in shares of Sanofi in the 3rd quarter valued at $29,000. Palisade Asset Management LLC purchased a new position in Sanofi in the 3rd quarter worth about $30,000. Annis Gardner Whiting Capital Advisors LLC increased its stake in Sanofi by 544.4% in the 4th quarter. Annis Gardner Whiting Capital Advisors LLC now owns 696 shares of the company’s stock worth $34,000 after purchasing an additional 588 shares in the last quarter. Finally, Larson Financial Group LLC raised its holdings in Sanofi by 48.9% during the 4th quarter. Larson Financial Group LLC now owns 810 shares of the company’s stock worth $39,000 after buying an additional 266 shares during the period. 14.03% of the stock is currently owned by institutional investors and hedge funds.

Sanofi Price Performance

Sanofi stock opened at $42.38 on Friday. The firm has a market cap of $102.75 billion, a PE ratio of 11.84, a P/E/G ratio of 1.04 and a beta of 0.34. The company has a debt-to-equity ratio of 0.17, a quick ratio of 0.22 and a current ratio of 1.01. The firm’s 50 day moving average price is $44.70 and its two-hundred day moving average price is $46.31. Sanofi has a twelve month low of $41.85 and a twelve month high of $52.68.

Sanofi Increases Dividend

The business also recently declared an annual dividend, which was paid on Wednesday, June 3rd. Stockholders of record on Monday, May 4th were issued a dividend of $2.4225 per share. The ex-dividend date was Monday, May 4th. This represents a dividend yield of 559.0%. This is an increase from Sanofi’s previous annual dividend of $2.04. Sanofi’s dividend payout ratio is presently 49.16%.

Wall Street Analyst Weigh In

SNY has been the subject of a number of analyst reports. BNP Paribas Exane lowered shares of Sanofi from an “outperform” rating to a “neutral” rating and set a $50.00 price objective for the company. in a research note on Monday, April 20th. Weiss Ratings raised shares of Sanofi from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Wednesday, May 13th. Morgan Stanley set a $52.00 price target on shares of Sanofi in a report on Friday, May 1st. Sanford C. Bernstein upgraded shares of Sanofi to a “strong-buy” rating in a research report on Thursday, March 19th. Finally, Wall Street Zen lowered shares of Sanofi from a “strong-buy” rating to a “buy” rating in a research note on Saturday, February 21st. Two research analysts have rated the stock with a Strong Buy rating, three have issued a Buy rating and ten have assigned a Hold rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $51.00.

Sanofi Profile

Sanofi (NASDAQ:SNY) is a multinational pharmaceutical company headquartered in France that researches, develops, manufactures and markets prescription medicines, vaccines and consumer healthcare products. The company operates across multiple therapeutic areas, including immunology, rare diseases, oncology, cardiovascular and metabolic diseases, and vaccines through its Sanofi Pasteur division. Sanofi sells products to hospitals, clinics, governments and retail pharmacies, with a broad global footprint and significant presence in Europe, North America and emerging markets.

Key commercial offerings include specialty biologics and established small-molecule medicines.